• Je něco špatně v tomto záznamu ?

A need for predictive and personalized approach in osteoporosis treatment: individual treatment plan

Pikner Richard, Švagr Martin, Novák Vladimír, Vachek Jan

. 2022 ; 27 (1) : 13-16.

Jazyk angličtina Země Česko

Typ dokumentu přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22022119

Osteoporosis is a frequent, multifactorial disease and represents a significant and increasing healthcare burden in Europe. For osteoporosis treatment several drugs groups (SERM: bisphosphonates, denosumab, teriparatide) have been approved with different biological effects and further are expected. The question if every medication is suitable for all patients, is opened. We may stratify patients by individual fracture risk assessment but often there many others individual factors affecting medication choice. Age, life expectancy, falls, kidney function are very important. Preparing individual treatment plans for each patient is the way how to handle with it. In younger osteoporotic women we have to expect 20-25 years of care and sequential therapy, long term therapy with “drug holiday” is to be considered. This new strategy should be accompanied by more flexible reimbursement rules.

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc22022119
003      
CZ-PrNML
005      
20221016222120.0
007      
ta
008      
220919s2022 xr f 000 0|eng||
009      
AR
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Pikner, Richard $7 xx0053349 $u Department of Clinical Biochemistry and Bone Metabolism, Klatovska Hospital, Klatovy, Czech Republic; Department of Clinical Biochemistry and Haematology, Faculty of Medicine Pilsen, Charles University Prague, Pilsen, Czech Republic; Faculty of Health Care Studies, University of West Bohemia, Pilsen, Czech Republic;
245    12
$a A need for predictive and personalized approach in osteoporosis treatment: individual treatment plan / $c Pikner Richard, Švagr Martin, Novák Vladimír, Vachek Jan
504    __
$a Literatura
520    9_
$a Osteoporosis is a frequent, multifactorial disease and represents a significant and increasing healthcare burden in Europe. For osteoporosis treatment several drugs groups (SERM: bisphosphonates, denosumab, teriparatide) have been approved with different biological effects and further are expected. The question if every medication is suitable for all patients, is opened. We may stratify patients by individual fracture risk assessment but often there many others individual factors affecting medication choice. Age, life expectancy, falls, kidney function are very important. Preparing individual treatment plans for each patient is the way how to handle with it. In younger osteoporotic women we have to expect 20-25 years of care and sequential therapy, long term therapy with “drug holiday” is to be considered. This new strategy should be accompanied by more flexible reimbursement rules.
650    _7
$a lidé $7 D006801 $2 czmesh
650    17
$a osteoporóza $x farmakoterapie $x terapie $7 D010024 $2 czmesh
650    _7
$a selektivní modulátory estrogenních receptorů $x aplikace a dávkování $x klasifikace $x terapeutické užití $7 D020845 $2 czmesh
650    _7
$a riziko $7 D012306 $2 czmesh
650    _7
$a osteoporotické fraktury $x prevence a kontrola $7 D058866 $2 czmesh
650    17
$a individualizovaná medicína $x metody $7 D057285 $2 czmesh
655    _7
$a přehledy $7 D016454 $2 czmesh
700    1_
$a Švagr, Martin $7 xx0144096 $u Department of Orthopaedics, Klatovska Hospital, Klatovy, Czech Republic
700    1_
$a Novák, Vladimír $7 _AN110894 $u Department of Clinical Biochemistry and Bone Metabolism, Klatovska Hospital, Klatovy, Czech Republic
700    1_
$a Vachek, Jan, $d 1981- $7 pna2010554305 $u Department of Internal Medicine, Klatovska Hospital, Klatovy, Czech Republic 5
773    0_
$t Clinical osteology $x 2571-1326 $g Roč. 27, č. 1 (2022), s. 13-16 $w MED00197385
856    41
$u https://www.prolekare.cz/casopisy/clinical-osteology/2022-1-24/a-need-for-predictive-and-personalized-approach-in-osteoporosis-treatment-individual-treatment-plan-130731 $y plný text volně přístupný
910    __
$a ABA008 $b B 2839 $c 474 b $y p $z 0
990    __
$a 20220919104527 $b ABA008
991    __
$a 20221016222120 $b ABA008
999    __
$a ok $b bmc $g 1839273 $s 1173389
BAS    __
$a 3
BMC    __
$a 2022 $b 27 $c 1 $d 13-16 $i 2571-1326 $m Clinical Osteology $x MED00197385
LZP    __
$c NLK189 $d 20221016 $a NLK 2022-33/dk

Najít záznam

Citační ukazatele

Možnosti archivace